Companies / Larimar Therapeutics, Inc. / Activity
Activity — Larimar Therapeutics, Inc.
21 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Clayton Russell Executive | Grant | Common Stock | $0 | +26K +55.97% | 71,443 0.07% of shares | low |
| Jan 26, 2026 | Ben-Maimon Carole CEO | Grant | Common Stock | $0 | +100K +37.33% | 368,276 0.35% of shares | low |
| Jan 26, 2026 | Celano Michael Executive | Grant | Common Stock | $0 | +38K +21.10% | 215,785 0.21% of shares | low |
| Jan 26, 2026 | Shankar Gopi Executive | Grant | Common Stock | $0 | +26K +50.46% | 76,443 0.07% of shares | low |
| Feb 27, 2026 | Thomas Frank E Director | Buy | Common Stock | $25.0K | +5K +250.00% | 7,000 <0.01% of shares | low |
| Feb 27, 2026 | Sherman Jeffrey W Director | Buy | Common Stock | $25.0K | +5K | 5,000 <0.01% of shares | low |
| Feb 27, 2026 | Hamilton Thomas Edward Director | Buy | Common Stock | $500.0K | +100K +17.71% | 664,798 0.64% of shares | high |
| Feb 27, 2026 | Deerfield Mgmt, L.P. Director | Buy | Common Stock | $4.16M | +832K +11.36% | 8,153,107 7.85% of shares | high |
| Feb 27, 2026 | Deerfield Mgmt, L.P. Director | Buy | Common Stock | $5.42M | +1.1M +11.36% | 10,622,928 10.23% of shares | high |
| Feb 27, 2026 | Deerfield Mgmt, L.P. Director | Buy | Common Stock | $5.42M | +1.1M +11.36% | 10,622,957 10.23% of shares | high |
| Feb 27, 2026 | Deerfield Mgmt, L.P. Director | Buy | Common Stock | $10.00M | +2.0M +47.53% | 6,207,982 5.98% of shares | high |
| May 19, 2026 | Truitt Joseph Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| May 19, 2026 | Hamilton Thomas Edward Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| May 19, 2026 | Thomas Frank E Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| May 19, 2026 | Sherman Jeffrey W Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| May 19, 2026 | Leff Jonathan S Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| May 19, 2026 | Deerfield Mgmt, L.P. Director | Grant | Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |
| Jan 26, 2026 | Clayton Russell Executive | Grant | Stock Option (Right to Buy) | — | +154K | 153,822 0.15% of shares | low |
| Jan 26, 2026 | Ben-Maimon Carole CEO | Grant | Stock Option (Right to Buy) | — | +601K | 600,600 0.58% of shares | low |
| Jan 26, 2026 | Celano Michael Executive | Grant | Stock Option (Right to Buy) | — | +226K | 225,622 0.22% of shares | low |
| Jan 26, 2026 | Shankar Gopi Executive | Grant | Stock Option (Right to Buy) | — | +154K | 153,822 0.15% of shares | low |